Bodal Chemicals (524370) Stock Overview
Engages in the manufacture and sale of dyestuffs, dyes intermediates, and other chemicals in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
524370 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Bodal Chemicals Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹67.99 |
| 52 Week High | ₹81.50 |
| 52 Week Low | ₹41.25 |
| Beta | -0.12 |
| 1 Month Change | 25.26% |
| 3 Month Change | 41.94% |
| 1 Year Change | 6.33% |
| 3 Year Change | -2.89% |
| 5 Year Change | -32.75% |
| Change since IPO | 9,612.88% |
Recent News & Updates
524370: Future Returns Will Rise As Upcoming Board Results Support Earnings Confidence
Analysts have nudged their price target on Bodal Chemicals to ₹107, reflecting slightly higher assumptions for revenue growth and future P/E, partly offset by a modest trim to profit margin expectations and a small adjustment to the discount rate. What's in the News A board meeting is scheduled for Feb 14, 2026 to consider and approve standalone unaudited financial results for the quarter and nine months ended Dec 31, 2025.524370: Future Returns Will Rise As Board Meeting Supports Earnings Confidence
Analysts have reset their price target on Bodal Chemicals to ₹107, reflecting updated views on the discount rate, revenue growth, profit margin, and future P/E assumptions. What's in the News A board meeting is scheduled for February 14, 2026 to review and approve standalone unaudited financial results for the quarter and nine months ended December 31, 2025 (Key Developments).Recent updates
524370: Future Returns Will Rise As Upcoming Board Results Support Earnings Confidence
Analysts have nudged their price target on Bodal Chemicals to ₹107, reflecting slightly higher assumptions for revenue growth and future P/E, partly offset by a modest trim to profit margin expectations and a small adjustment to the discount rate. What's in the News A board meeting is scheduled for Feb 14, 2026 to consider and approve standalone unaudited financial results for the quarter and nine months ended Dec 31, 2025.524370: Future Returns Will Rise As Board Meeting Supports Earnings Confidence
Analysts have reset their price target on Bodal Chemicals to ₹107, reflecting updated views on the discount rate, revenue growth, profit margin, and future P/E assumptions. What's in the News A board meeting is scheduled for February 14, 2026 to review and approve standalone unaudited financial results for the quarter and nine months ended December 31, 2025 (Key Developments).524370: Future Returns Will Rise As Board Review Supports Earnings Confidence
Analysts have reiterated their fair value estimate for Bodal Chemicals at ₹107.0, with only small tweaks to inputs like the discount rate and future P/E assumptions. The headline target remains unchanged, while reflecting updated model fine tuning.524370: Future Returns Will Rise As Stable Assumptions Support Earnings Confidence
Analysts have maintained their fair value estimate for Bodal Chemicals at ₹107.0, with only small adjustments to inputs such as the discount rate and future P/E assumptions. This signals that their overall view on the stock's price target is broadly unchanged.524370: Future Returns Will Rise As Lower Risk Supports Earnings Confidence
Analysts have modestly revised their price target for Bodal Chemicals upward to ₹107.00, reflecting slightly lower perceived risk and marginally improved confidence in the company’s long term earnings profile. What's in the News A board meeting is scheduled on November 12, 2025, to review and approve standalone and consolidated unaudited financial results for the quarter and half year ended September 30, 2025 (company filing).524370: Future Returns Will Benefit From Lower Risk And Stable Profit Margins
Analysts have modestly increased their price target on Bodal Chemicals to reflect a fair value of ₹107.00 per share, highlighting slightly lower perceived risk and stable expectations for revenue growth, margins, and future earnings multiples. What's in the News Board meeting scheduled for November 12, 2025, to consider and approve standalone and consolidated unaudited financial results for the quarter and half year ended September 30, 2025, and to take up any other business (company filing) Shareholders approved the appointment of M/s.524370: Future Returns Will Benefit From Stable Margins And Modest Multiple Expansion
Analysts have nudged their price target on Bodal Chemicals slightly higher to ₹107.0 per share from ₹107, reflecting a marginally increased discount rate and modestly higher expectations for the company’s future valuation multiples while keeping growth and margin assumptions broadly unchanged. What's in the News A board meeting is scheduled for November 12, 2025 to consider and approve standalone and consolidated unaudited financial results for the quarter and half year ended September 30, 2025, and to take up any other business (Key Developments).524370: Future Results Will Benefit From Rising Profit Margins And Sustained Revenue Momentum
Analysts have maintained their price target for Bodal Chemicals at ₹107.00, citing slightly improved profit margin and revenue growth outlooks. These factors offset a modest increase in the discount rate and a lower estimated future price-to-earnings ratio.524370: Future Results Will Benefit From Lower Discount Rate And Steady Profitability
Narrative Update: Bodal Chemicals Analyst Price Target Revision Analysts have maintained their price target for Bodal Chemicals at ₹107.00. They stated that minor adjustments to the discount rate and forward-looking estimates were not significant enough to warrant a change in valuation.Analysts Raise Bodal Chemicals Price Target as Profit Margin Forecast Improves Amid Company Updates
Analysts have raised their price target for Bodal Chemicals from ₹92.5 to ₹107.0. This reflects improved profit margin forecasts, despite slightly lower revenue growth expectations. What's in the News Bodal Chemicals approved the appointment of M/s.
Saykha Benzene Project Nearing Viability Will Strengthen Future Prospects
Expansion into benzene downstream and salt-free dyes is set to boost revenue and margins, leveraging existing resources efficiently.Shareholder Returns
| 524370 | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | 1.6% | 1.1% | 0.4% |
| 1Y | 6.3% | -1.5% | 4.0% |
Return vs Industry: 524370 exceeded the Indian Chemicals industry which returned -1.5% over the past year.
Return vs Market: 524370 exceeded the Indian Market which returned 3.9% over the past year.
Price Volatility
| 524370 volatility | |
|---|---|
| 524370 Average Weekly Movement | 8.1% |
| Chemicals Industry Average Movement | 7.0% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in IN Market | 10.2% |
| 10% least volatile stocks in IN Market | 4.7% |
Stable Share Price: 524370 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 524370's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1986 | 2,213 | Sureshbhai Patel | www.bodal.com |
Bodal Chemicals Limited engages in the manufacture and sale of dyestuffs, dyes intermediates, and other chemicals in India. The company’s dye intermediates primarily include H-Acid, vinyl sulphone, K-Acid, gamma acid, DASA, FC acid, SPVS, OA sulpho VS, and beta naphthol; and dyestuffs, such as reactive dyes, acid dyes, direct dyes, and liquid dyes. It also provides chemicals comprising of sulphuric acid, oleum, thionyl chloride, and acetanilide.
Bodal Chemicals Limited Fundamentals Summary
| 524370 fundamental statistics | |
|---|---|
| Market cap | ₹8.56b |
| Earnings (TTM) | ₹302.72m |
| Revenue (TTM) | ₹18.72b |
Is 524370 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 524370 income statement (TTM) | |
|---|---|
| Revenue | ₹18.72b |
| Cost of Revenue | ₹10.51b |
| Gross Profit | ₹8.21b |
| Other Expenses | ₹7.91b |
| Earnings | ₹302.72m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.40 |
| Gross Margin | 43.87% |
| Net Profit Margin | 1.62% |
| Debt/Equity Ratio | 77.2% |
How did 524370 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/01 17:46 |
| End of Day Share Price | 2026/04/30 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Bodal Chemicals Limited is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Nikhil Shetty | BP Wealth Management Private Limited |
| Anil Burra | FirstCall Research |
| Chirag Shah | ICICIdirect.com |